HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fusidic acid in dermatology: an updated review.

Abstract
Studies on the clinical efficacy of fusidic acid in skin and soft-tissue infections (SSTIs), notably those due to Staphylococcus aureus, are reviewed. Oral fusidic acid (tablets dosed at 250 mg twice daily, or a suspension for paediatric use at 20 mg/kg/day given as two daily doses) has shown good efficacy and tolerability. Similarly, plain fusidic acid cream or ointment used two or three times daily in SSTIs such as impetigo are clinically and bacteriologically effective, with minimal adverse events. Combination formulations of fusidic acid with 1% hydrocortisone or 0.1% betamethasone achieve excellent results in infected eczema by addressing both inflammation and infection. A new lipid-rich combination formulation provides an extra moisturizing effect. Development of resistance to fusidic acid has remained generally low or short-lived and can be minimized by restricting therapy to no more than 14 days at a time.
AuthorsHelmut Schöfer, Lene Simonsen
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2010 Jan-Feb Vol. 20 Issue 1 Pg. 6-15 ISSN: 1167-1122 [Print] France
PMID20007058 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Anti-Bacterial Agents
  • Drug Combinations
  • Glucocorticoids
  • Fusidic Acid
Topics
  • Administration, Oral
  • Administration, Topical
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Drug Combinations
  • Fusidic Acid (administration & dosage, therapeutic use)
  • Glucocorticoids (administration & dosage)
  • Humans
  • Skin Diseases, Infectious (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: